Roundhill GLP-1 & Weight Loss ETF (OZEM)
35.29
-0.05
(-0.14%)
USD |
NASDAQ |
Feb 20, 10:20
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.59% | 0.09% | 59.16M | 34640.33 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 1.94% | 37.00% | 4.777M |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide capital appreciation. The Fund pursues its objective by seeking exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help individuals lose weight, maintain an ideal weight, and/or maintain body composition during weight loss. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Roundhill Investments |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of February 20, 2026.
Asset Allocation
As of January 31, 2026.
| Type | % Net |
|---|---|
| Cash | 0.09% |
| Stock | 99.68% |
| Bond | 0.07% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.16% |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide capital appreciation. The Fund pursues its objective by seeking exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help individuals lose weight, maintain an ideal weight, and/or maintain body composition during weight loss. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Roundhill Investments |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |